Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

How Long Should we Give Steroids for Patients With Severe PCP (HOW LONG)

NCT07328984 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07328984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
How Long Should we Give Steroids for Patients With Severe PCP (HOW LONG)
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 30, 2026
Completion date
June 30, 2029
Enrollment
416 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumocystis, pneumocystis carinii; infection, resulting from hiv disease, pneumocystis jiroveci pneumonia, pneumocystis jirovecii infection, pneumocystis pneumonia, pneumocystosis associated with aids, pneumocystosis; pneumonia (etiology)